 | Indolactam V | Ki | 8.3 [1], 135.6 [2], 1900.0 [3] |
 | Staurosporine | IC50 | 41.0 [1] |
 | Phorbol 12,13-dibutyrate | Ki | 0.8 [1], 12.0 [2], 21.6 [3], 100.0 [4] |
 | Balanol | IC50 | 4.0 [1], 23.0 [2], 30.0 [3], 32.0 [4] |
 | 8-Dec-1-ynyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,4,5,6-tetrahydro-2H-benzo[e][1,4]diazocin-3-one | Ki | 10.7 [1], 114.0 [2], 134.0 [3], 730.0 [4], 933.0 [5] |
 | Balanol analog 5 | IC50 | 0.9 [1] |
 | (1S,3R,5R,9R,13R)-9-(Hydroxymethyl)-3-[4-(3-hydroxyphenyl)butyl]-16,16-dimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 7.4 [1], 140.0 [2] |
 | (2S,5S)-8-Decyl-5-(hydroxymethyl)-1-methyl-2-propan-2-yl-2,4,5,6-tetrahydro-1,4-benzodiazocin-3-one | Ki | 14.6 [1], 32.0 [2], 185.0 [3], 260.8 [4], 2771.0 [5] |
 | 8-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 1155.0 [1], 1160.0 [2], 22010.0 [3], 70600.0 [4], 70641.0 [5] |
 | Balanol analog 4 | IC50 | 5.0 [1] |
 | 2-[2,6-Dihydroxy-4-[3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 16.0 [1], 20.0 [2], 23.0 [3], 50.0 [4] |
 | Sotrastaurin | IC50 | 1.3 [1] |
 | (E)-2-(2-(Hydroxymethyl)-4-(3-isobutyl-5-methylhexylidene)-5-oxo-tetrahydrofuran-2-yl)ethyl pivalate | Ki | 0.9 [1], 103.0 [2] |
 | 8-Octyl-benzolactam-V9 | Ki | 216.0 [1], 220.0 [2], 10000.0 [3] |
 | 5-(3,4-Dimethoxyphenyl)-4-(1H-indol-5-ylamino)nicotinonitrile | IC50 | 350.0 [1] |
| 5-(3,4-Dimethoxyphenyl)-4-(1H-indol-5-ylamino)nicotinonitrile | Ki | 1600.0 [1] |
 | 4-(1H-Indol-5-ylamino)-2-phenylthieno[2,3-b]pyridine-5-carbonitrile | IC50 | 370.0 [1], 2000.0 [2], 33000.0 [3] |
 | Bisindolylmaleimide i | IC50 | 8.7 [1], 32.0 [2] |
 | Aplysiatoxin | Ki | 0.41 [1], 12.0 [2] |
 | Debromoaplysiatoxin | Ki | 0.2 [1], 9.7 [2] |
 | N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 500000.0 [1] |
 | (Z)-(2-(Hydroxymethyl)-4-(3-isobutyl-5-methylhexylidene)-5-oxo-tetrahydrofuran-2-yl)methyl pivalate | Ki | 1.16 [1] |
 | Benzolactam-V8 | Ki | 410.0 [1], 1700.0 [2] |
 | 4-[(4-Methyl-1H-indol-5-yl)amino]-2-phenylthieno[2,3-b]pyridine-5-carbonitrile | IC50 | 370.0 [1], 3400.0 [2] |
 | 4-(4-Methyl-1H-indol-5-ylamino)-5-(4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)nicotinonitrile | IC50 | 51.0 [1] |
 | (2S,5S)-9-Decyl-5-(hydroxymethyl)-2-isopropyl-1-methyl-2,4,5,6-tetrahydro-1,4-benzodiazocin-3-one | Ki | 1.8 [1], 5.9 [2] |
 | N'-(3-Pyridin-4-yl-2,6-naphthyridin-1-yl)ethane-1,2-diamine | IC50 | 20.0 [1] |
 | 4-Methyl-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | IC50 | 500000.0 [1] |
 | N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | IC50 | 500000.0 [1] |
 | N-[3-(4-Pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | IC50 | 23000.0 [1] |
 | [(4E)-2-(Hydroxymethyl)-4-[(4-hydroxyphenyl)methylidene]-5-oxooxolan-2-yl]methyl 4-methyl-3-propan-2-ylpentanoate | Ki | 1.4 [1], 170.0 [2] |
 | 2-[3-[(Dimethylamino)methyl]phenyl]-4-[(4-methyl-1H-indol-5-yl)amino]thieno[2,3-b]pyridine-5-carbonitrile | IC50 | 26.0 [1] |
| 2-[3-[(Dimethylamino)methyl]phenyl]-4-[(4-methyl-1H-indol-5-yl)amino]thieno[2,3-b]pyridine-5-carbonitrile | Ki | 96.0 [1] |
 | 3-(1H-Indol-3-yl)-4-[3-(4-methylpiperazin-1-yl)naphthalen-1-yl]pyrrole-2,5-dione | IC50 | 7.3 [1] |
 | N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-acetamide | IC50 | 500000.0 [1] |
 | 4-(4-Methyl-1H-indol-5-ylamino)-5-(4-(2-(4-methylpiperazin-1-yl)ethoxy)styryl)nicotinonitrile | IC50 | 41.0 [1] |
 | 1-Piperazin-1-yl-3-pyridin-4-yl[2,6]naphthyridine | IC50 | 31.0 [1] |
 | (1S,3R,5R,9R,13R)-9-(Hydroxymethyl)-16,16-dimethyl-3-(4-phenylbutyl)-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 9.8 [1], 130.0 [2] |
 | 2-[2,6-Dihydroxy-4-[2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 0.9 [1], 1.0 [2] |
 | (1R,3R,4R,5S,9R,13R)-9-(Hydroxymethyl)-3-[4-(3-hydroxyphenyl)butyl]-4,16,16-trimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 0.46 [1], 22.0 [2] |
 | 2-Methoxy-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | IC50 | 100000.0 [1], 500000.0 [2] |
 | N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]naphthalene-2-carboxamide | IC50 | 500000.0 [1] |
 | 5-Hydroxymethyl-2-isopropyl-1-undecyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 415.0 [1], 30300.0 [2] |
 | [(1R,3S,7S,8E,11S,12S,13E,17R,21R,23S)-11,21-Dihydroxy-17-[(1R)-1-hydroxyethyl]-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octanoate | Ki | 2.5 [1], 65.9 [2] |
 | (10S,13S)-13-(Hydroxymethyl)-9-methyl-10-propan-2-yl-3,9,12-triazatricyclo[6.6.1.04,15]pentadeca-1,4(15),5,7-tetraene-11-thione | Ki | 67.5 [1], 2950.0 [2] |
 | 7-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 92.0 [1], 10000.0 [2] |
 | 9-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 149.0 [1], 6150.0 [2] |
 | (3E)-5-(2,2-Dimethylpropoxymethyl)-5-(hydroxymethyl)-3-[5-methyl-3-(2-methylpropyl)hexylidene]oxolan-2-one | Ki | 1890.0 [1], 101000.0 [2] |
 | [(4E)-2-(Hydroxymethyl)-4-(4-methyl-3-propan-2-ylpentylidene)-5-oxooxolan-2-yl]methyl 4-hydroxybenzoate | Ki | 980.0 [1], 16900.0 [2] |
 | [(4E)-2-(Hydroxymethyl)-4-[5-methyl-3-(2-methylpropyl)hexylidene]-5-sulfanylideneoxolan-2-yl]methyl 2,2-dimethylpropanoate | Ki | 3.13 [1], 173.4 [2] |
 | O-[[(4E)-2-(Hydroxymethyl)-4-[5-methyl-3-(2-methylpropyl)hexylidene]-5-oxooxolan-2-yl]methyl] 2,2-dimethylpropanethioate | Ki | 20.6 [1], 606.0 [2] |
 | 2-[2,6-Dihydroxy-4-[[2-[(4-hydroxybenzoyl)amino]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]oxycarbonyl]benzoyl]-3-hydroxybenzoic acid | IC50 | 5000.0 [1] |
 | [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 3-[4-[2-(4-methylphenyl)ethynyl]phenoxy]propanoate | Ki | 31.3 [1], 35.8 [2] |
 | [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 2-[4-[2-(4-methylphenyl)ethynyl]phenoxy]acetate | Ki | 46.4 [1], 47.7 [2] |
 | [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 4-[4-[2-(4-methylphenyl)ethynyl]phenoxy]butanoate | Ki | 11.6 [1], 11.9 [2] |
 | [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 4-[2-(4-methylphenyl)ethynyl]benzoate | Ki | 2.74 [1], 5.4 [2] |
 | (1R,3R,5R,9R,13R)-9-(Hydroxymethyl)-3-(4-phenylbutyl)-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 170.0 [1], 6800.0 [2] |
 | [2-[(2R,4R)-4-[(1R,3S,4S,5S)-3-(Benzylamino)-4-hydroxy-5-methylcyclohexyl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-oxoethyl] pentanoate | Ki | 2500.0 [1], 2700.0 [2] |
 | [(1R,3S,7S,8E,11S,12S,13E,17R,21S,23S)-11,21-Dihydroxy-17-[(1R)-1-hydroxyethyl]-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octanoate | Ki | 64.2 [1], 494.4 [2] |
 | [(1S,3E,5S,9S,11S,15R,19R,23E,24S)-11-Tert-butyl-1,15-dihydroxy-19-[(1R)-1-hydroxyethyl]-23-(2-methoxy-2-oxoethylidene)-2,2-dimethyl-17-oxo-6,12,18,25,26-pentaoxatricyclo[19.3.1.15,9]hexacos-3-en-24-yl] octanoate | Ki | 6.3 [1], 85.4 [2] |
 | [2-[(4-Hydroxyphenyl)methyl]cyclopentyl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonylbenzoyl)benzoate | IC50 | 50.0 [1] |
 | 2-[2,6-Dihydroxy-4-[2-[(4-hydroxyphenyl)methyl]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 30.0 [1] |
 | 2-[2,6-Dihydroxy-4-[2-(4-hydroxyphenoxy)cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 20.0 [1] |
 | 2-[2,6-Dihydroxy-4-[4-[(4-hydroxyphenyl)methyl]pyrrolidin-3-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 5.0 [1], 1800.0 [2] |
 | [4-[(4-Hydroxyphenyl)methyl]pyrrolidin-3-yl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonylbenzoyl)benzoate | IC50 | 100.0 [1] |
 | [(1R,2R,6S,10S,11R,13S,14R,15R)-13-Butanoyloxy-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] butanoate | Ki | 0.55 [1], 70.2 [2] |
 | [(4E)-2-(Hydroxymethyl)-4-[5-methyl-3-(2-methylpropyl)hexylidene]oxolan-2-yl]methyl 2,2-dimethylpropanoate | Ki | 219.0 [1], 6620.0 [2] |
 | 2-[2,6-Dihydroxy-4-[(1R,2R)-2-[(4-hydroxybenzoyl)amino]cycloheptyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 90.0 [1] |
 | Balanol analog 3 | IC50 | 50.0 [1] |
 | N-[4-Hydroxy-2-[4-[(1S,3R,5R,9R,13R)-9-(hydroxymethyl)-16,16-dimethyl-7,11-dioxo-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecan-3-yl]butyl]phenyl]acetamide | Ki | 690.0 [1], 8700.0 [2] |
 | N-[2-Hydroxy-4-[4-[(1S,3R,5R,9R,13R)-9-(hydroxymethyl)-16,16-dimethyl-7,11-dioxo-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecan-3-yl]butyl]phenyl]acetamide | Ki | 36.0 [1], 290.0 [2] |
 | (1S,3R,5R,9R,13R)-3-[4-(2-Bromo-5-hydroxyphenyl)butyl]-9-(hydroxymethyl)-16,16-dimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 3.5 [1], 66.0 [2] |
 | (1S,3R,5R,9R,13R)-3-[4-(2,4-Dibromo-5-hydroxyphenyl)butyl]-9-(hydroxymethyl)-16,16-dimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 4.1 [1], 93.0 [2] |
 | (1S,3R,5R,9R,13R)-9-(Hydroxymethyl)-16,16-dimethyl-3-[4-(2,4,6-tribromo-3-hydroxyphenyl)butyl]-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 6.9 [1], 79.0 [2] |
 | (1S,3R,5R,9R,13R)-3-[4-(3-Hydroxy-4-iodophenyl)butyl]-9-(hydroxymethyl)-16,16-dimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 1.3 [1], 82.0 [2] |
 | (1S,3R,5R,9R,13R)-3-[4-(5-Hydroxy-2-iodophenyl)butyl]-9-(hydroxymethyl)-16,16-dimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 4.6 [1], 110.0 [2] |
 | (1S,3R,5R,9R,13R)-9-(Hydroxymethyl)-3-[4-(3-methoxyphenyl)butyl]-16,16-dimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 9.7 [1], 330.0 [2] |
 | 4-Chloro-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | IC50 | 100000.0 [1], 500000.0 [2] |
 | 2-[2,6-Dihydroxy-4-[(3R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 4.0 [1], 32.0 [2] |
 | Phorbol 12-myristate 13-acetate | Ki | 0.8 [1] |
 | Imatinib | IC50 | 100000.0 [1] |
 | Dasatinib | IC50 | 50000.0 [1] |
 | Alvocidib | IC50 | 890.0 [1] |
 | Rottlerin | IC50 | 3000.0 [1] |
 | Bryostatin 1 | Ki | 0.44 [1] |
 | Go-6976 | IC50 | 446.0 [1] |
 | Enzastaurin | IC50 | 1000.0 [1] |
 | Teleocidin B4 | Ki | 0.32 [1] |
 | Ruboxistaurin | IC50 | 250.0 [1] |
 | Doramapimod | IC50 | 1900.0 [1] |
 | Purvalanol B | IC50 | 100000.0 [1] |
 | Purvalanol A | IC50 | 100000.0 [1] |
 | Gsk-690693 | IC50 | 14.0 [1] |
 | (5e)-5-(Quinolin-6-Ylmethylidene)-2-[(Thiophen-2-Ylmethyl)amino]-1,3-Thiazol-4(5h)-One | Ki | 318.0 [1] |
 | (5Z)-5-(Quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one | Ki | 320.0 [1] |
 | (2S,3R)-3-Hydroxy-N-[3-[(2R,3S,6S,8R)-8-[(E,3S,6S)-6-hydroxy-3,5-dimethylhept-4-enyl]-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]propyl]-2-methyl-4-[[2-[(2S,3S,6R)-3-methyl-6-[(E)-2-oxopent-3-enyl]oxan-2-yl]acetyl]amino]butanamide | Ki | 27000.0 [1] |
 | A-674563 | Ki | 360.0 [1] |
 | Rac-syn-Balanol | IC50 | 32.0 [1] |
 | 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol | IC50 | 100000.0 [1] |
 | 1-(Tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 100000.0 [1] |
Calculator
